Early-stage biotech developing tyrosine kinase inhibitors for treating cancer.
Industry: Health Care
First Day Return: +60.6%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 03/21/2019 |
Offer Price | $18.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 9.3 |
Deal Size ($mm) | $167 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 04/16/2019 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $167 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | San Diego, CA, United States |
Founded | 2013 |
Employees at IPO | 50 |
Website www.tptherapeutics.com |